What is the recommended outpatient treatment for respiratory syncytial virus (RSV) infection?

Outpatient RSV Treatment

Outpatient RSV treatment is entirely supportive—there is no specific antiviral therapy recommended, and management focuses on maintaining hydration, monitoring oxygen saturation, and avoiding ineffective interventions like bronchodilators, corticosteroids, or antibiotics unless bacterial co-infection is documented. 1, 2

Core Management Principles

The cornerstone of outpatient RSV management is supportive care only. This approach is consistently emphasized across both established guidelines and recent evidence 1, 2, 3, 4.

What TO Do:

• Assess hydration status and oral intake ability at every encounter 1
• Ensure adequate fluid and nutrition intake (oral route preferred)
• Monitor oxygen saturation if the infant appears distressed—supplemental oxygen is indicated only if SpO2 persistently falls below 90% 1
• Educate families on warning signs requiring re-evaluation (increased work of breathing, poor feeding, lethargy)
• Emphasize hand hygiene to prevent transmission to other household members 1, 5

What NOT To Do:

The evidence is clear about avoiding multiple interventions that lack benefit:

• Do NOT routinely use bronchodilators (albuterol or other beta-agonists)—these should only be continued if there is documented objective clinical improvement after a carefully monitored trial 1
• Do NOT use corticosteroids routinely 1, 2
• Do NOT use ribavirin routinely 1
• Do NOT prescribe antibiotics unless there are specific signs of bacterial co-infection 1, 2
• Do NOT perform chest physiotherapy 1, 2
• Do NOT use nebulized hypertonic saline or epinephrine in the outpatient setting 2

Clinical Monitoring Algorithm

For previously healthy infants:

• If feeding well, maintaining hydration, and no respiratory distress → continue outpatient management with close follow-up
• If SpO2 remains ≥90%, breathing comfortably, and taking adequate fluids → reassurance and supportive care only

Red flags requiring hospitalization consideration:

• Persistent SpO2 <90%
• Significant respiratory distress (severe retractions, grunting, apnea)
• Inability to maintain hydration
• Age <3 months with moderate-severe symptoms
• Underlying cardiopulmonary disease or prematurity (<35 weeks gestation) 1

Important Caveats

Premature infants and those with hemodynamically significant heart or lung disease require closer monitoring as they are at higher risk for severe disease 1. These patients may need earlier hospitalization even with seemingly mild symptoms.

The guideline 1 mentions that a trial of bronchodilators is "an option," but this should be interpreted cautiously—if attempted, it must include objective assessment (e.g., respiratory rate, work of breathing score), and the medication should be discontinued immediately if no clear benefit is demonstrated. Most recent evidence 2 does not recommend bronchodilators at all.

Prevention Counseling

While treating the current episode, counsel families on:

• Avoiding passive smoke exposure 1
• Promoting breastfeeding to reduce future lower respiratory tract disease risk 1
• Hand hygiene and avoiding contact with sick individuals 2, 3

The Bottom Line

RSV is a self-limited viral illness in most cases, resolving within 1-2 weeks 2, 4. The medical provider's role is to ensure adequate supportive care, avoid unnecessary interventions that may cause harm or expense without benefit, and identify the minority of patients who require escalation to hospital-based care.